Hercules Capital Inc (HTGC)
18.61
-0.21
(-1.12%)
USD |
NYSE |
Nov 21, 14:33
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.023B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 32.83% |
| Valuation | |
| PE Ratio | 9.213 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 7.176 |
| Price to Book Value | 1.633 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.48 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.9492 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 57.22% |
Profile
| Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology. |
| URL | https://www.htgc.com |
| Investor Relations URL | https://investor.htgc.com |
| HQ State/Province | California |
| Sector | Financials |
| Industry | Capital Markets |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Feb. 14, 2025 (est.) |
| Last Earnings Release | Oct. 30, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 13, 2024 |
Ratings
Profile
| Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology. |
| URL | https://www.htgc.com |
| Investor Relations URL | https://investor.htgc.com |
| HQ State/Province | California |
| Sector | Financials |
| Industry | Capital Markets |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Feb. 14, 2025 (est.) |
| Last Earnings Release | Oct. 30, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 13, 2024 |